Blood Cancer: Drugs
Commons · Question 77180 · Tabled 15 Sep 2025 · Department of Health and Social Care · Official record
Answered 13 Oct 2025
Question
Asked by Matt Vickers
To ask the Secretary of State for Health and Social Care, what steps he is taking to monitor progress on access to new NHS-approved drugs for blood cancer patients.
Answer
Answered by Karin Smyth, 13 Oct 2025
The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based recommendations for the National Health Service on whether new medicines represent a clinically and cost-effectiv...